Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis
source: pixabay.com

Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis

A study conducted by researchers at Nagoya University in Japan and researchers from Yale University in the United States was recently published in the European Respiratory Journal.  This study utilized single-cell…

Continue Reading Collaborative Study Provides Increased Understanding of Idiopathic Pulmonary Fibrosis
These Words Are Not Helpful: “Your Test Results are Negative. You Are No Doubt Imagining Most of Your Pain”
source: pixabay.com

These Words Are Not Helpful: “Your Test Results are Negative. You Are No Doubt Imagining Most of Your Pain”

  The patient sitting in front of this physician was later diagnosed with severe chronic fatigue syndrome (myalgic encephalomyelitis or ME/CFS). But for now, the patient had to endure humiliation…

Continue Reading These Words Are Not Helpful: “Your Test Results are Negative. You Are No Doubt Imagining Most of Your Pain”

A New Opportunity for Narcolepsy Patients

Acknowledgment: This story is sponsored by Takeda and is promoted through the Patient Worthy Collaborative Content program. We only publish content that embodies our mission of providing relevant, vetted and valuable information to the…

Continue Reading A New Opportunity for Narcolepsy Patients
Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome
source: pixabay.com

Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome

As we've learned more about individuals facing long-term symptoms from COVID-19, we have heard more and more about how it mimics other chronic conditions. For instance, those suffering from chronic…

Continue Reading Understanding COVID-19 Long-Haulers Can Help Us Better Understand Chronic Fatigue Syndrome
Phase 2 PRA023 Trial for UC Begins
source: pixabay.com

Phase 2 PRA023 Trial for UC Begins

Clinical trials are important research tools to help understand the safety, efficacy, and tolerability of potential treatments. According to a news release from July 19, 2021, biotechnology company Prometheus Biosciences,…

Continue Reading Phase 2 PRA023 Trial for UC Begins